These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 6822291)

  • 1. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S; Garthoff B; Knorr A
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of antihypertensive action of nitrendipine.
    Kazda S; Garthoff B; Luckhaus G
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S956-62. PubMed ID: 6085384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
    Knorr A; Stoepel K
    Arzneimittelforschung; 1981; 31(12):2062-4. PubMed ID: 7199298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension.
    Sterzel RB; Huelsemann JL; McKenzie DE; Wilcox CS
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1024-7. PubMed ID: 6085360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors involved in the antihypertensive action of calcium antagonists.
    Garthoff B; Kazda S; Knorr A; Thomas G
    Hypertension; 1983; 5(4 Pt 2):II34-8. PubMed ID: 6345375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure.
    Knorr A; Garthoff B
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):316-22. PubMed ID: 6476986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of systemic hemodynamic response to a new calcium entry blocker, nitrendipine.
    Fouad FM; Aboul-Khair M; Tarazi RC
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S383-6. PubMed ID: 6184573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive effects of dihydropyridine derivatives.
    Kamei C; Kurokawa K; Tasaka K
    Arzneimittelforschung; 1985; 35(9):1377-80. PubMed ID: 2935160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: alterations in baroreflex sensitivity.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):376-82. PubMed ID: 6747841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies of the antihypertensive effect of nitrendipine.
    Stoepel K; Heise A; Kazda S
    Arzneimittelforschung; 1981; 31(12):2056-61. PubMed ID: 7199297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment.
    Pedrinelli R; Tarazi RC
    J Pharmacol Exp Ther; 1985 Jun; 233(3):636-42. PubMed ID: 2989491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of a new dihydropyridine calcium antagonist.
    Kimura Y; Fukui H; Tanaka M; Okamoto M; Morino A; Miura A; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1329-35. PubMed ID: 3790182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nisoldipine (BAY K 5552), a new calcium antagonist. Antihypertensive effect in conscious, unrestrained renal hypertensive dogs.
    Knorr A
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):141-50. PubMed ID: 7165419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on the antihypertensive effects of m-nifedipine, nifedipine and nitrendipine in conscious rats and rabbits].
    Rao MR
    Yao Xue Xue Bao; 1987 Aug; 22(8):570-4. PubMed ID: 3450160
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitrendipine: hemodynamic effects in conscious normotensive and spontaneously hypertensive rats.
    Pegram BL; Kobrin I; Sesoko S; Frohlich ED
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1016-23. PubMed ID: 6085359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
    Micheli D; Collodel A; Semeraro C; Gaviraghi G; Carpi C
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.